You are currently viewing our desktop site, do you want to download our app instead?
Moneyweb Android App Moneyweb iOS App Moneyweb Mobile Web App

NEW SENS search and JSE share prices

More about the app

LATEST NEWS FOR Adcock Ingram Holdings Ltd.  

Adcock Ingram is a leading South African pharmaceutical manufacturer listed on the Johannesburg Stock Exchange. The company's mission is to provide quality products that improve the health and lives of people in the markets they serve.... [more info]

No one has died from Covid-19 vaccines in SA – Saphra

14 Sep 2021 /  Akhona Matshoba   96
But anyone who suffers adverse effects as a direct result of Covid-19 vaccination can expect compensation.

Bidvest shrugs off Covid woes with record profit

7 Sep 2021 /  Ciaran Ryan   
Trading profit is up 47.8%, with strong performance from Services, Automotive and Commercial Products.

SA health minister says C.1.2 Covid variant not a threat for now

3 Sep 2021 /  Alexander Winning and Wendell Roelf, Reuters   10
The variant was first identified in May and has now been seen in all of the country's nine provinces.

Covid-19 impacts on Adcock Ingram’s year-end results

26 Aug 2021 /  Simon Brown  
CEO Andy Hall describes some of the ‘swings and roundabouts’ as the company weathers the pandemic.

South Africans and shares: 37% of us own them

26 Aug 2021 /  Simon Brown    4
Nedbank's Preston Narainsamy talks DRD results and Massmart buying OneCart. Adcock Ingram CEO Andy Hall on company results as it gets squeezed by the pandemic. Kylie Purcell of Finder as its research shows 37% of South Africans directly own shares.

Market Watcher: JSE (non)moves, Jackson Hole, Adcock Ingram, Datatec and MultiChoice

25 Aug 2021 /  Fifi Peters  
David Shapiro – Chief Global Equity Strategist, Sasfin Securities.

EM-Turkish lira rises in muted FX trade as focus turns to Jackson Hole

25 Aug 2021 /  Sagarika Jaisinghani, Reuters  
SA's rand firmed 0.4% before the release of rebased GDP figures.

Cape Town’s vaccine manufacture coup

22 Jul 2021 /  Palesa Mofokeng   6
Ramaphosa hails Biovac deal to produce more than 100m doses of Pfizer-BioNTech vaccine in the Mother City.

Tobacco companies looking for a new future

13 May 2021 /  Simon Brown   
Kruger International's Mia Kruger unpacks the latest Naspers/Prosus share shuffle and the Lewis update. Rishaad Hajee from Philip Morris on the end of cigarette sales. Small caps analyst, Anthony Clark takes a look at the Ascendis debt deal.

Corporate kowtowing

19 Apr 2021 /  Ann Crotty  
Chinese companies kneel to the government.

Profiting off delistings

15 Mar 2021 /  Keith McLachlan   2
A speculative list of JSE stocks with the list of traits that could make them consider delisting.

Lower flu infections put pressure on Adcock Ingram’s profit

25 Feb 2021 /  Simon Brown  
Viv Govender of Rand Swiss on the market's reaction to the budget. AECI CEO Mark Dytor unpacks their results as geographic diversification pays off and Adcock Ingram's CEO, Andy Hall, talks results showing healthcare continues to struggle under the pandemic.

Adcock Ingram’s profit drops as pandemic hits demand

24 Feb 2021 /  Promit Mukherjee, Reuters  
The hit was somewhat cushioned by strong demand for immunity-boosting products.

Finding value in SA’s small- and mid-cap sector

25 Nov 2020 /  Nompu Siziba   1
Diversification across sectors is the best hedge against bad luck, stresses Keith McLachlan from Alpha Asset Management.

How to fix the JSE

6 Oct 2020 /  Keith McLachlan   14
There is something deeply wrong with the stock market, and it appears systemic.

Enter company name or share code:

Enter company name or share code:


Follow us:

Search Articles:
Click a Company: